These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 4087483)

  • 1. [Serial biochemical and histological studies on fatty liver in obese patients].
    Ueno T; Nagata E; Sakisaka S; Kumashiro R; Miura T; Gondo K; Akashi T; Matsuzaki T; Wada T; Kuwaki T
    Nihon Shokakibyo Gakkai Zasshi; 1985 Nov; 82(11):2782-9. PubMed ID: 4087483
    [No Abstract]   [Full Text] [Related]  

  • 2. An obese 14-year-old girl with persistently elevated liver-associated enzymes.
    Shaffer RT; Carrougher JG; Kadakia SC; Goodman ZD
    Semin Liver Dis; 1992 Nov; 12(4):429-34. PubMed ID: 1361243
    [No Abstract]   [Full Text] [Related]  

  • 3. Fenretinide ameliorates insulin resistance and fatty liver in obese mice.
    Koh IU; Jun HS; Choi JS; Lim JH; Kim WH; Yoon JB; Song J
    Biol Pharm Bull; 2012; 35(3):369-75. PubMed ID: 22382323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between arterial oxygen tension and serum aminotransferases in morbidly obese patients with fatty liver.
    Nanji AA; French SW; Freeman JB
    Clin Chem; 1985 Sep; 31(9):1571-2. PubMed ID: 4028411
    [No Abstract]   [Full Text] [Related]  

  • 5. The relationship between serum transaminase activities and fatty liver in children with simple obesity.
    Noguchi H; Tazawa Y; Nishinomiya F; Takada G
    Acta Paediatr Jpn; 1995 Oct; 37(5):621-5. PubMed ID: 8533591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical studies on liver injuries in obese subjects. (1) Relationship between blood biochemistry and hepatic morphology].
    Yoshitsugu M; Maehara M; Sugaya H; Harada T
    Nihon Shokakibyo Gakkai Zasshi; 1982 Feb; 79(2):223-30. PubMed ID: 7098111
    [No Abstract]   [Full Text] [Related]  

  • 8. Serum alanine aminotransferase to aspartate aminotransferase ratio and degree of fatty liver in morbidly obese patients.
    Nanji AA; French SW; Freeman JB
    Enzyme; 1986; 36(4):266-9. PubMed ID: 3569188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Non-alcoholic fatty liver].
    Zwimpfer J
    Praxis (Bern 1994); 2000 Oct; 89(43):1757-8. PubMed ID: 11103621
    [No Abstract]   [Full Text] [Related]  

  • 10. [Common biochemical changes in obesity related liver diseases].
    Gao CF
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jul; 12(7):433. PubMed ID: 15268812
    [No Abstract]   [Full Text] [Related]  

  • 11. Persistent hyperaminotransferasemia resolving after weight reduction in obese children.
    Vajro P; Fontanella A; Perna C; Orso G; Tedesco M; De Vincenzo A
    J Pediatr; 1994 Aug; 125(2):239-41. PubMed ID: 8040771
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Importance of hypertransaminasemia in blood donors. Study performed in patients of the Saint Thomas Hospital].
    Narváez E; de Lozano D; Perez Ferrari R
    Rev Med Panama; 1983 Jan; 8(1):45-9. PubMed ID: 6828781
    [No Abstract]   [Full Text] [Related]  

  • 13. Evaluation of ultrasonographic fatty liver and severity of coronary atherosclerosis, and obesity in patients undergoing coronary angiography.
    Açikel M; Sunay S; Koplay M; Gündoğdu F; Karakelleoğlu S
    Anadolu Kardiyol Derg; 2009 Aug; 9(4):273-9. PubMed ID: 19666428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Liver changes in psoriasis vulgaris].
    Diwok K; Leithäuser W; Nowotny P; Moldenhauer E; Dabels J
    Dtsch Z Verdau Stoffwechselkr; 1971; 31(5):231-5. PubMed ID: 5161458
    [No Abstract]   [Full Text] [Related]  

  • 15. Evidence for liver injury in the setting of obstructive sleep apnea.
    Byrne TJ; Parish JM; Somers V; Aqel BA; Rakela J
    Ann Hepatol; 2012; 11(2):228-31. PubMed ID: 22345340
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-alcoholic fatty liver disease: a multicentre clinical study by the Italian Association for the Study of the Liver.
    Loguercio C; De Simone T; D'Auria MV; de Sio I; Federico A; Tuccillo C; Abbatecola AM; Del Vecchio Blanco C;
    Dig Liver Dis; 2004 Jun; 36(6):398-405. PubMed ID: 15248380
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin resistance and whole body energy homeostasis in obese adolescents with fatty liver disease.
    Perseghin G; Bonfanti R; Magni S; Lattuada G; De Cobelli F; Canu T; Esposito A; Scifo P; Ntali G; Costantino F; Bosio L; Ragogna F; Del Maschio A; Chiumello G; Luzi L
    Am J Physiol Endocrinol Metab; 2006 Oct; 291(4):E697-703. PubMed ID: 16684857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship between aminotransferase levels and histopathological findings in patients with nonalcoholic steatohepatitis.
    Sonsuz A; Basaranoglu M; Ozbay G
    Am J Gastroenterol; 2000 May; 95(5):1370-1. PubMed ID: 10811364
    [No Abstract]   [Full Text] [Related]  

  • 19. Serum galectin-3 levels in patients with nonalcoholic fatty liver disease.
    Yilmaz Y; Eren F; Kurt R; Yonal O; Polat Z; Senates E; Bacha M; Imeryuz N
    Clin Biochem; 2011 Aug; 44(12):955-8. PubMed ID: 21635880
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of pioglitazone on biochemical indices of non-alcoholic fatty liver disease in upper body obesity.
    Shadid S; Jensen MD
    Clin Gastroenterol Hepatol; 2003 Sep; 1(5):384-7. PubMed ID: 15017657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.